The last Recall Enforcement Report for Rosuvastatin with NDC was initiated on as a Class II recall due to cgmp deviations: recalling drug products following an fda inspection.
The last Recall Enforcement Report for Rosuvastatin with NDC was initiated on as a Class II recall due to cgmp deviations: recalling drug products following an fda inspection. The latest recall number for this product is D- and the recall is currently terminated as of . Recall Number.
Letters and medicine recalls sent to healthcare professionals in July 2024. A rosuvastatin and pitavastatin (singl Therapeutic area: Cardiovascular
The last Recall Enforcement Report for Rosuvastatin with NDC was initiated on as a Class II recall due to cgmp deviations: recalling drug products following an fda inspection. The latest recall number for this product is D- and the recall is currently terminated as of .
MPS 2925 – Rosuvastatin 5mg, 10mg and 20mg tablets 17th August 20 Product Recall Information notice – Abbott recalls two infant formula
The last Recall Enforcement Report for Rosuvastatin with NDC was initiated on as a Class II recall due to cgmp deviations: recalling drug products following an fda inspection.
The last Recall Enforcement Report for Rosuvastatin with NDC was initiated on as a Class II recall and it is currently terminated.
rosuvastatin and aspirin. BMC Med The Neural Bases of Interoceptive Encoding and Recall in Healthy Adults and Adults With Depression.
The last Recall Enforcement Report for Rosuvastatin with NDC was initiated on as a Class II recall due to cgmp deviations: recalling drug products following an fda inspection. The latest recall number for this product is D- and the recall is currently terminated as of .
Comments